ArticleJournal of managed care & specialty pharmacy2021

Effects of early vs delayed progression on clinical and economic outcomes in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors as first-line therapy: results from the IMPACT RCC claims data analysis.

Thomas E Hutson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.